Hims & Hers Health, Inc. Class A Common Stock (NY: HIMS )

Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

February 05, 2024

Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more.

3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024

January 25, 2024

Growth stocks haven't kept up with wider market growth, creating a unique opportunity to capture long-term upside with these companies.

Topics Artificial Intelligence

Exposures Artificial Intelligence

7 Growth Stocks to Buy and Hold Forever: January 2024

January 23, 2024

This unique telemedicine company looks poised for a bright future.

Where Will Hims & Hers Stock Be in 5 Years?

January 15, 2024

Hims & Hers Health is growing at an unprecedented rate.

1 Healthcare Stock to Buy Hand Over Fist Going Into 2024

December 08, 2023

Hims & Hers is a pharmaceutical marketing, product, and distribution firm with a telehealth component.

It Is Time To Buy Hims & Hers Stock

November 24, 2023

Via Talk Markets

Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money

January 22, 2024

Healthcare is nearly a fifth of America's economy. Ride these high-flying healthcare stocks to monster gains.

Telehealth stocks capture healthcare and medicine's future but don't bet the bank on a company that can't cut it.

Topics Economy

Exposures Economy

3 Stocks to Profit from the Telehealth Transformation

January 12, 2024

Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care

January 11, 2024

Hard numbers and the CEO's own words point to shares exploding next year.

Underestimating This Stock Could Be Wall Street's Biggest Mistake in 2024

January 02, 2024

Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication

Weight Watchers gains from Oprah’s GLP-1 weight-loss

January 02, 2024

Investors may be overlooking an incredible growth opportunity with Hims & Hers stock.

Topics Artificial Intelligence

Exposures Artificial Intelligence

Is Hims & Hers Stock a Buy Now?

November 16, 2023

The S&P 500 had a strong year in 2023, returning about 24% to investors from the beginning of the year to the end. Some of that was a bounce back from a poor 2022 when it was down over 11%.

2023 Year In Review

January 02, 2024

Via Talk Markets

Topics Stocks

Exposures US Equities

The 3 Hottest Telehealth Stocks to Watch in 2024

January 01, 2024

Uncover the hottest telehealth stocks for 2024, on the back of a market projected to reach a whopping $504.2 billion by 2030.

LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing

10 Health Care Stocks With Whale Alerts In Today's Session

December 25, 2023

Via Benzinga

LifeMD expands telehealth GLP-1weight-loss service with Medifast

December 19, 2023

These stocks are still screaming buys for my long-term portfolio.

My 2024 Financial Resolution: Buying More of These 3 Stocks

December 11, 2023

The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage

Ozempic vs. Mounjaro:: Battle of the bulge

December 04, 2023

Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss

Exposures Product Safety

December 04, 2023

This emerging consumer healthcare company could compound at more than 25% annually.

This Growth Stock Could 10x in 10 Years

November 29, 2023

E-health and wellness platform operator Hims & Hers Inc. reported a stellar quarter of growth that highlighted its expanded line of personalized products

Hims & Hers earnings highlight expanded personalized treatments

November 29, 2023

Dive into the dynamic world of top telehealth stocks. Discover our expert analysis on the gems shaping the future of digital healthcare.

5 Telehealth Stocks That Have Nothing But Upside

November 26, 2023

Be thankful for Wall Street's discounts on these potential market-beating stock ideas.

My Take: 4 Strong Growth Stocks to Buy This Week

November 26, 2023

These rapidly expanding companies could make you richer, even with a minimal investment.

2 No-Brainer Stocks to Buy Right Now for Less Than $50

November 24, 2023

Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy.

2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth

November 23, 2023

As of Nov. 17, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 5 Health Care Stocks That May Collapse In November

November 17, 2023

Via Benzinga

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

November 07, 2023

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.

Via Benzinga

Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday

November 07, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Exposures US Equities

Is Hims & Hers Health Stock a Buy After Strong Earnings?

November 07, 2023

The company reported another good quarter and announced a buyback. Is HIMS stock a buy?